Cardiac safety of diabetes therapies and postmarketing requirements.
Faich
Gerald A
GA
United BioSource Corporation, Blue Bell, PA, 19422 USA.
Stemhagen
Annette
A
D006331:Heart Diseases / Q000139:chemically induced* / Q000453:epidemiology; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D018570:Risk Assessment; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone